Reduced production of hyperalgesic substances by mononuclear cells from aged rats incubated with carrageenan: Role of interleukin 2 and prostaglandins

Inflammation Research

Volumn 52, Issue 3, 2003, Pages 119-125

  Pereira, L S M ^a   Ferreira Alves, D L ^a   De Resende, M A ^a   Romualdo, V A ^a   Dos Reis, W G P ^a   Lopes, M T P ^a   Santoro, M M ^a   Francischi, J N ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Aging; Hyperalgesia; Interleukin 2 (IL 2); Mononuclear cells; Prostaglandin E2 (PGE2)

Indexed keywords

ANTIBODY; ANTISERUM; ATROPINE; CARRAGEENAN; INDOMETACIN; INTERLEUKIN 2; INTERLEUKIN 2 ANTIBODY; MEPYRAMINE MALEATE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

AGING; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERALGESIA; IMMUNOREACTIVITY; INCUBATION TIME; MONONUCLEAR CELL; NONHUMAN; PAW EDEMA; PROTEIN FUNCTION; PURIFICATION; RAT; STATISTICAL SIGNIFICANCE; SUPERNATANT;

AGING; ANIMALS; CARRAGEENAN; CELL SEPARATION; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; INDICATORS AND REAGENTS; INDOMETHACIN; INTERLEUKIN-2; LIPIDS; MONOCYTES; PAIN MEASUREMENT; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

EID: 0037363603     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110300024     Document Type: Article

References (28)

1. Ginaldi L, De Martinis M, D'Ostilio A. The immune system in the elderly. II. Specific Cellular Immunity. Immunologic Research 1999; 20(2): 109-15.
2. Frasca D, Doria G. Recombinant cytokines as an approach to immune reconstitution in aging. Developmental & Comparative Immunology 1997; 21(6): 525-30.
3. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mechanisms of ageing and development 1998; 102: 199-209.
4. Pawelec G, Wagner W, Adibzadeh M, Engel A. T cell immunosenescence in vitro and in vivo. Experimental Gerontology 1999; 34: 419-29.
5. Poole S, Cunha FQ, Ferreira SH. (1999) Hyperalgesia from subcutaneous cytokines. In: Watkins LR, Maier SF, editors. Basel: Birkhäuser Verlag, 1999: 59-87.
6. 2. Prostaglandins 1978; 16: 31-7.
7. Davis AJ, Perkins MN. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in rat. British Journal of Pharmacology 1994; 113(1): 63-8.
8. Di Rosa M, Giroud JP, Willoughby DA. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentin. Journal of Pathology 1971; 104: 15-29.
9. Resende MA, Reis WGP, Pereira LSM, Ferreira W, De Lima ME, Santoro MM et al. Hyperalgesia and edema responses induced by rat peripheral blood mononuclear cells incubated with carrageenan. Inflammation 2001; 25(5): 277-85.
10. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
11. Waynforth HB, Flecknell PA. Methods of obtaining body fluids. In Experimental and surgical technique in the rat. London: Academic Press 1994: 75-8.
12. Francischi JN, Chaves CT, Moura ACL, Lima AS, Ferreira-Alves DL, Rocha AO et al. Selective inhibitors of cyclooxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. British Journal of Pharmacology 2002; 137(6): 837-44.
13. Samuelson, B. Isolation and identification of prostaglandins from human seminal plasma. J Biol Chem 1963; 238: 3229-34.
14. Moncada, S, Ferreira, SH, Vane, JR. Bioassay of prostaglandins and biologically active substances derived from arachidonic acid. In: Frolich JC, editor. New York: Raven Press 1978: 211-36.
15. Finney DJ. Statistical method in biological assay. London: Charles Griffin & Co. Ltd., 1971: 668pp.
16. rd edition, San Diego, USA 1999: 17.
17. Randall LD, Sellito JJ. A method for measurement of analgesic activity on inflammed tissues. Archives International Pharmacodynamics 1957; 113: 233-49.
18. Feldman M, Male D. Cell cooperation in the immune response. In: Roitt I, Brostoff J, Male D, editors. London: Gower Medical Publishing Immunology 1989: 8.1-8.11.
19. Faulds D, Goa KL, Benfiel P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in immunoregulatory disorders. Drugs 1993; 45: 953.
20. A A, Smith KA. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunological reviews 1995; 148: 35-44.
21. Symons JA, Wood NC, Di Giovane FS, Duff GW. Soluble IL 2 receptor in rheumatic arthritis. J. Immunol. 1988; 141: 2612-18.
22. Sporri B, Kovanen PE, Sasaki A, Yoshimura A, Leonard W. JAB/SOCS 1/SSI-1 is an interleukin-2-induced of IL-2 signaling. Blood 2001; 97: 221-26.
23. Mc Murray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001; 14(6): 324-33.
24. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology 1971; 231: 232-35.
25. Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Dieu M, Remacle J, Michiels C. PGF2α, a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment. Am J Pathol 2001; 159(1): 345-57.
26. Taiwo YO, Levine JD. Effects of cylooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Research 1990; 537: 372-4.
27. 2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol 1998; 275: C661-C668.
28. Beharka AA, Wu D, Han SN, Meydani SN. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Dev 1997; 93: 59-77.